Further Information
TGFBR1, transforming growth factor, beta receptor 1, AAT5, ACVRLK4, ALK-5, ALK5, LDS1A, LDS2A, SKR4, TGFR-1, TGF-beta receptor type I, TGF-beta receptor type-1, TGF-beta type I receptor, activin A receptor type II-like kinase, 53kD, activin A receptor type II-like kinase, 53kDa, activin receptor-like kinase 5, serine/threonine-protein kinase receptor R4, tbetaR-I, transforming growth factor beta receptor I, transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD), transforming growth factor-beta receptor type I
Peptide ELISA: antibody detection limit dilution 1:64000.Western Blot:Approx 55kDa band observed in Rat Liver lysates (calculated MW of 55.6kDa according to Rat NP_036907.2). Recommended concentration: 0.1-0.3ug/ml. Primary incubation was 1 hour.Immunohistochemistry:Paraffin embedded Human Adrenal Gland and Small Intestine. Recommended concentration: 5ug/ml.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Mouse, Dog, Pig, Cow
The immunogen for this antibody is: TDGLCFVSVTETTD
7046
transforming growth factor, beta receptor 1
TGFBR1
Homo sapiens
Liquid
NP_004603.1, NP_001124388.1
4759226
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Signal Transduction ,Cancer ,Stem Cell
This antibody is expected to recognize both reported isoforms (NP_004603.1; NP_001124388.1). The immunizing peptide represents part of a potential extracellular domain.
P36897